A detailed history of Royal London Asset Management LTD transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Royal London Asset Management LTD holds 875,878 shares of TMO stock, worth $468 Million. This represents 1.3% of its overall portfolio holdings.

Number of Shares
875,878
Previous 868,393 0.86%
Holding current value
$468 Million
Previous $461 Million 10.44%
% of portfolio
1.3%
Previous 1.34%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$528.82 - $599.43 $3.96 Million - $4.49 Million
7,485 Added 0.86%
875,878 $509 Million
Q4 2023

Feb 13, 2024

BUY
$431.41 - $532.94 $3.67 Million - $4.54 Million
8,518 Added 0.99%
868,393 $461 Million
Q3 2023

Nov 14, 2023

BUY
$498.29 - $574.41 $11.2 Million - $12.9 Million
22,409 Added 2.68%
859,875 $435 Million
Q2 2023

Aug 11, 2023

BUY
$508.46 - $591.13 $24.6 Million - $28.6 Million
48,322 Added 6.12%
837,466 $437 Million
Q1 2023

May 15, 2023

BUY
$535.0 - $604.82 $7.89 Million - $8.92 Million
14,740 Added 1.9%
789,144 $455 Million
Q4 2022

Feb 09, 2023

BUY
$484.71 - $571.37 $2.31 Million - $2.73 Million
4,775 Added 0.62%
774,404 $427 Million
Q3 2022

Nov 14, 2022

BUY
$507.19 - $604.49 $5.2 Million - $6.2 Million
10,252 Added 1.35%
769,629 $391 Million
Q2 2022

Aug 12, 2022

BUY
$500.9 - $612.21 $3.57 Million - $4.37 Million
7,130 Added 0.95%
759,377 $413 Million
Q1 2022

May 13, 2022

BUY
$524.0 - $644.92 $2.5 Million - $3.07 Million
4,762 Added 0.64%
752,247 $445 Million
Q4 2021

Oct 18, 2022

SELL
$569.0 - $667.24 $4.19 Million - $4.91 Million
-7,360 Reduced 0.98%
747,485 $499 Million
Q4 2021

Jan 18, 2022

SELL
$569.0 - $667.24 $4.19 Million - $4.91 Million
-7,360 Reduced 0.98%
747,485 $499 Million
Q3 2021

Oct 18, 2022

BUY
$509.53 - $609.78 $1.81 Million - $2.17 Million
3,552 Added 0.47%
754,845 $431 Million
Q3 2021

Nov 02, 2021

BUY
$509.53 - $609.78 $1.81 Million - $2.17 Million
3,552 Added 0.47%
754,845 $431 Million
Q2 2021

Oct 18, 2022

SELL
$441.0 - $508.24 $3.57 Million - $4.11 Million
-8,084 Reduced 1.06%
751,293 $379 Million
Q2 2021

Jul 14, 2021

BUY
$441.0 - $508.24 $85.5 Million - $98.6 Million
193,915 Added 34.79%
751,293 $383 Million
Q1 2021

Oct 17, 2022

SELL
$439.85 - $518.83 $88.8 Million - $105 Million
-201,999 Reduced 26.6%
557,378 $255 Million
Q1 2021

Apr 13, 2021

BUY
$439.85 - $518.83 $24.7 Million - $29.2 Million
56,259 Added 11.23%
557,378 $254 Million
Q4 2020

Jan 29, 2021

SELL
$435.06 - $527.66 $3.07 Million - $3.72 Million
-7,056 Reduced 1.39%
501,119 $233 Million
Q3 2020

Nov 04, 2020

BUY
$359.77 - $441.52 $34.5 Million - $42.3 Million
95,878 Added 23.25%
508,175 $221 Million
Q2 2020

Jul 31, 2020

BUY
$275.2 - $362.34 $3.33 Million - $4.38 Million
12,093 Added 3.02%
412,297 $145 Million
Q1 2020

May 01, 2020

BUY
$255.3 - $340.05 $32.4 Million - $43.2 Million
127,098 Added 46.54%
400,204 $114 Million
Q4 2019

Feb 05, 2020

BUY
$271.93 - $328.04 $3.43 Million - $4.14 Million
12,616 Added 4.84%
273,106 $88.8 Million
Q3 2019

Nov 12, 2019

SELL
$268.46 - $305.43 $570,477 - $649,038
-2,125 Reduced 0.81%
260,490 $75.9 Million
Q2 2019

Jul 31, 2019

BUY
$257.51 - $295.55 $1.51 Million - $1.73 Million
5,855 Added 2.28%
262,615 $77.1 Million
Q1 2019

Apr 30, 2019

BUY
$212.17 - $273.72 $2.91 Million - $3.76 Million
13,737 Added 5.65%
256,760 $0
Q4 2018

Jan 29, 2019

BUY
$208.47 - $251.98 $13.8 Million - $16.7 Million
66,393 Added 37.59%
243,023 $54.1 Million
Q3 2018

Nov 08, 2018

BUY
$205.57 - $244.32 $715,589 - $850,477
3,481 Added 2.01%
176,630 $0
Q2 2018

Sep 19, 2018

BUY
$203.14 - $219.53 $35.2 Million - $38 Million
173,149 New
173,149 $35.9 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $209B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Royal London Asset Management LTD Portfolio

Follow Royal London Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal London Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Royal London Asset Management LTD with notifications on news.